856834-95-2

Basic information

• Product Name: 3-BROMO-2-CHLORO-5-NITRO-6-PICOLINE
• Synonyms: 3-BROMO-2-CHLORO-5-NITRO-6-PICOLINE;3-Bromo-2-chloro-6-methyl-5-nitropyridine;5-Bromo-6-chloro-3-nitro-2-picoline;3-bromo-2-chloro-5-nitro-6-picolin;2-Picoline, 5-bromo-6-chloro-3-nitro-
• CAS NO: 856834-95-2
• Molecular Formula: C₆H₄BrClN₂O₂
• Molecular Weight: 251.46516
• Mol File: 856834-95-2.mol

Chemical Properties

• Melting Point: 93℃
• Boiling Point: 296℃
• Flash Point: 133℃
• Appearance: /
• Density: 1.810
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -4.03±0.10(Predicted)
• CAS DataBase Reference: 3-BROMO-2-CHLORO-5-NITRO-6-PICOLINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BROMO-2-CHLORO-5-NITRO-6-PICOLINE(856834-95-2)
• EPA Substance Registry System: 3-BROMO-2-CHLORO-5-NITRO-6-PICOLINE(856834-95-2)

Safety Data

• Hazardous Substances Data: 856834-95-2(Hazardous Substances Data)

Upstream product

• 150935-62-9 2-amino-3-bromo-6-methyl-5-nitropyridine 
• 22280-62-2 6-methyl-5-nitro-2-pyridinamine 
• 28489-45-4 6-methyl-5-nitropyridin-2-ol 
• 3279-76-3 6-hydroxy-2-methylpyridine 
• 374633-33-7 3-bromo-2-hydroxy-6-methylpyridine 
• 500587-45-1 3,5-dibromo-2-hydroxy-6-methylpyridine 
• 874493-25-1 3-bromo-6-methyl-5-nitro-pyridin-2-ol 
• 1824-81-3 2-Amino-6-methylpyridine 
• 109-06-8 α-picoline 

Downstream Products

• 1049707-75-6 3-bromo-2-(4-chloro-3-trifluoromethylphenoxy)-6-methyl-5-nitropyridine 
• 1049707-80-3 2-(4-chloro-3-trifluoromethylphenoxy)-6-methyl-5-nitro-3-trimethylsilanylethynylpyridine 
• 1049707-76-7 2-(4-chloro-3-trifluoromethylphenoxy)-3-(4-fluorophenyl)-6-methyl-5-nitropyridine 
• 1049707-78-9 6-(4-chloro-3-trifluoromethylphenoxy)-5-(4-fluorophenyl)-2-methylpyridin-3-ylamine 

Relevant articles and documents

PYRAZOLE DERIVATIVES AS MALT1 INHIBITORS

Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT1. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R4, R5, R6, R5, G1, and G2 are defined herein.

INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1

The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compou

INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1

The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compou

NOVEL MICROBIOCIDES

Compounds of the formula (I) in which the substituents are as defined in claim 1 are suitable for use as microbiocides.